Antidepressants, Stimulants, Bipolar Drugs Flashcards
What class: Imipramine Amoxapine Nortiptyline Amitriptyline
Tricyclic Antidepressants
Treat major depression, affect noradrenergic and serotonergic synapses
Tricyclic Antidepressants
Side effects d/t blockage of muscarininc, adrenergic, histamine receptors
Tricyclic Antidepressants
Therapeutic activity begins in >2 weeks
Tricyclic Antidepressants, SSRIs
10-40 hour half life
Tricyclic Antidepressants
Metabolized by hepatic enzymes
Tricyclic Antidepressants
Eliminated by kidneys
Tricyclic Antidepressants, SSRIs, SNRIs, MAOIs, lithium salts
Antimuscarinic Effects
Blurred vision, dry mouth, urinary retention, constipation, glaucoma/epilepsy aggravation
Side effects include antimuscarinic effects
Tricyclic Antidepressants
Side effects: antimuscarinic, hypotension, tachycardia, sedation, weight gain, sexual dysfunction, seizures, psychiatric
Tricyclic Antidepressants
Fluoxetine, Citalopram, Escitalopram, Sertraline
Selective Serotonin Reuptake Inhibitors
Most widely prescribed antidepressants
SSRIs
1-3 day half life
SSRIs
High first pass hepatic metabolism
SSRIs
Block several liver enzymes
SSRIs
drug interaction potential
Demethylated to norfluozetine (has a 30 day half-life)
Fluoxetine
Early onset side effects: Nausea, Anxiety, Insomnia
SSRIs
Late onset side effects: Anorexia, Sexual Dysfunction, Mania if BPD
SSRIs
Drug Interactions d/t hepatic enzymes CYP2D6, CPY1A2, CYP3A4
TCAs, haloperidol, antiarrhythmics, beta-aderenergic antagonists
SSRIs
Venlafaxine
Duloxetine
SNRIs
Inhibit reuptake of 5-HT, NE
SNRIs
Treat patients refractory to SSRIs
SNRIs
11-12 hour half life
SNRIs
High binding to plasma proteins
duloxetine, SSRIs, TCAs
Metabolized by CYP1A2 and CYP2D6
duloxetine
Contraindicated if hepatic insufficiency
duloxetine
Side effects: Nausea, Anxiety, Sleep disturbance, Sexual dysfunction, BP/HR if high dose
SNRIs
Bupropion mechanism
inhibit dopamine reuptake
Useful for rapid-cycling BPD
Burpropion
Inhibit serotonin reuptake and blocks 5-HT2 receptors
Nefazodone
Increases NE/5-HT by blocking alpha2 receptors
Mirtazapine
Used in combo with TCAs
Atypical antidepressants bupropion, nefazodone, mirtazapine
Side effects include headache, nausea, tinnitus, insomnia, nervousness
Atypical antidepressants bupropion, nefazodone, mirtazapine
Irreversibly block monoamine oxidase
Phenelzine, Tranylcypromine, Selegiline
Third line drug for depression
MAOIs
Increase presynaptic concentration of monoamines
MAOIs
MAOIs therapeutic effect requires
2-4 weeks
Effects persist due to long-term irreversible blockage
MAOIs
MAO-A deaminates
NE, 5-HT, DA
Severe and unpredictable side effects (CNS + Cardiovascular)
MAOIs
MAOIs + SSRIs –>
Serotonin Syndrome
delirium, coma, hypertension, tachycardia, hyperthermia, hyperreflexia, tremor
Serotonin Syndrome
Contain tyramine
cheese, liver, chicken, beer, wine
Risk of Cheese effect
MAOIs (tyramine excess –> increase in catecholamines
headache, tachycardia, hypertension, seizure, stroke
Cheese effect
Decrease manic + depressive states in BPD
lithium salts
Combine with antidepressants, neuroleptics, antiepileptics
lithium salts
Several weeks for onset
lithium salts
Very low therapeutic index
lithium salts
Effective dose: 0.6-1.4
Toxic dose: 1.6-2.0 mEq/L
Sub for Na+ –> undesirable
lithium salts
Block hydrolysis of inositol phosphate –> prevent formation of phosphatidylinositol
lithium salts
Inhibit 5-HT1A, 5-HT1B
lithium salts
20-24 hour half life
lithium salts
CNS, cardiovascular, thyroid, renal, teratogenic, drug interaction side effects
lithium salts
Drug interactions with thiazide diuretics, NSAIDs
lithium salts
psychomotor stimulant
dextroamphetamine, methamphetamine
prevent narcolepsy, ADHD
dextroamphetamine, methylphenidate
Increase DA/NE in the brain
Stimulants: dextroamphetamine, methylphenidate, methamphetamine
Euphoria, anxiety, vertigo, insomnia, confusion, paranoia, psychoses, suicidal/homicidal tendencies, arrhythmia, hypertension, nausea, diarrhea, addition
Stimulants side effects
Phenelzine
Selegiline
Tranylcypromine
MAOIs